Muscle Atrophy Global Clinical Trials Review, H2, 2015

Published: October 2015
No. of Pages: 54
   

GlobalData''s clinical trial report, “Muscle Atrophy Global Clinical Trials Review, H2, 2015" provides an overview of Muscle Atrophy clinical trials scenario. This report provides top line data relating to the clinical trials on Muscle Atrophy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Muscle Atrophy Global Clinical Trials Review, H2, 2015

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Muscle Atrophy to Musculoskeletal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Muscle Atrophy to Musculoskeletal Clinical Trials 19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Muscle Atrophy Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Muscle Atrophy 34
Sep 23, 2015: Scholar Rock Presents First Data for Niche Modulator Inhibiting Myostatin Activation and Announces SRK-015 as Lead Drug Program 34
Clinical Trial Profile Snapshots 35
Appendix 51
Abbreviations 51
Definitions 51
Research Methodology 52
Secondary Research 52
About GlobalData 53
Contact Us 53
Disclaimer 53
Source 54

List of Tables

Muscle Atrophy Therapeutics, Global, Clinical Trials by Region, 2015* 6
Muscle Atrophy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Muscle Atrophy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Muscle Atrophy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Muscle Atrophy Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Muscle Atrophy Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Muscle Atrophy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Muscle Atrophy Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Muscle Atrophy to Musculoskeletal Clinical Trials, G7 Countries (%), 2015* 16
Muscle Atrophy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
Muscle Atrophy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
Proportion of Muscle Atrophy to Musculoskeletal Clinical Trials, E7 Countries (%), 2015* 20
Muscle Atrophy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 21
Muscle Atrophy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 22
Muscle Atrophy Therapeutics, Global, Clinical Trials by Phase, 2015* 23
Muscle Atrophy Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 24
Muscle Atrophy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 25
Muscle Atrophy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 26
Muscle Atrophy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Muscle Atrophy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Muscle Atrophy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Muscle Atrophy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Muscle Atrophy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

List of Figures

Muscle Atrophy Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Muscle Atrophy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Muscle Atrophy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Muscle Atrophy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Muscle Atrophy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Muscle Atrophy Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Muscle Atrophy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Muscle Atrophy to Musculoskeletal Clinical Trials, G7 Countries (%), 2015* 15
Muscle Atrophy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
Muscle Atrophy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
Proportion of Muscle Atrophy to Musculoskeletal Clinical Trials, E7 Countries (%), 2015* 19
Muscle Atrophy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 21
Muscle Atrophy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 22
Muscle Atrophy Therapeutics, Global, Clinical Trials by Phase (%), 2015* 23
Muscle Atrophy Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 24
Muscle Atrophy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 25
Muscle Atrophy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 26
Muscle Atrophy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Muscle Atrophy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Muscle Atrophy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Muscle Atrophy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Muscle Atrophy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
GlobalData Methodology 52

Published By: GlobalData
Product Code: GlobalData32783


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we´┐Żll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Pharmaceuticals market as per your needs. Get the best of Pharmaceuticals research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: